Regulation Establishing The No Small Amount Of Doping

Original Language Title: Verordnung zur Festlegung der nicht geringen Menge von Dopingmitteln

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now

Read the untranslated law here: http://www.gesetze-im-internet.de/dmmv_2013/BJNR168710013.html

Regulation establishing the no small amount of doping (doping quantities regulation – DmMV) DmMV Ausfertigung date: 24.06.2013 full quotation: "doping quantity regulation from 24 June 2013 (Gazette I p. 1687)" footnote (+++ text detection from: 29.6.2013 +++) the V as article 2 of the V v. 24.6.2013 I 1687 by the Federal Ministry of health in consultation with the Federal Ministry of the Interior after consultation by experts with the consent of the Federal Council decided. It is according to article 3 clause 1 of this V on the 29.6.2013 entered into force.
-The not inconsiderable amount of substances within the meaning of sec. 6a paragraph 2a sentence 1 of the German medicines Act is the amount specified in the system. The not inconsiderable amount specified for the free connection of the substance concerned.

System (reference: BGBl. I 2013, 1688 - 1692) I) anabolic substances 1. Anabolic Androgenic Steroids a) exogenous Anabolic Androgenic Steroids not small amount of 1-Androstenediol 3 000 mg 1-Androstendione 3 000 mg Bolandiol 3 000 mg Bolasterone - depot preparations 100 mg - other preparations 150 mg Boldenone 1 000 mg Boldion 3 000 mg Calusteron - depot preparations 100 mg - other preparations 150 mg Clostebol - depot preparations 80 mg - other preparations 900 mg of Danazol 3 000 mg Dehydrochlormethyltestosteron - depot preparations 100 mg - other preparations 150 mg Desoxymethyltestosteron - depot preparations
  100 mg - other preparations 150 mg Drostanolon 1 015 mg Ethylestrenol 450 mg Fluoxymesterone - depot preparations 100 mg - other preparations 150 mg Formebolon - depot preparations 100 mg - other preparations 150 mg Furazabol - depot preparations 100 mg - other preparations 150 mg Gestrinone 45 mg 4-Hydroxytestosteron 1 500 mg Mestanolon - depot preparations 100 mg - other preparations 150 mg Mesterolone 1 500 mg Metandienone - depot preparations 100 mg - other preparations 150 mg Metenolone - depot preparations 150 mg - other preparations 1 500 mg Methandriol - depot preparations 100 mg - other preparations
  150 mg Methasteron - depot preparations 100 mg - other preparations 150 mg Methyldienolon 45 mg methyl-1-testosterone depot preparations 100 mg - other preparations 150 mg Methylnortestosteron - depot preparations 100 mg - other preparations 150 mg Methyltestosterone - depot preparations 100 mg - other preparations 150 mg Metribolon, synonymous with Methyltrienolone 45 mg Mibolerone - depot preparations 100 mg - other preparations 150 mg Nandrolone 45 mg 19-Norandrostenedione 3 000 mg Norboleton 450 mg Norclostebol 1 500 mg Norethandrolon 450 mg of Oxabolon 75 mg Oxandrolone - depot preparations 100 mg - other preparations 150 mg Oxymesterone -. Depot-Zubereitungen 100 mg - other preparations 150 mg Oxymetholon - depot preparations 100 mg - other preparations 150 mg Prostanozol 1 500 mg Quinbolon 1 500 mg of Stanozolol - depot preparations 100 mg - other preparations 150 mg Stenbolon 1 500 mg 1-testosterone THG 1500 mg 45 mg of trenbolone of 150 mg other substances related to Anabolic-Androgenic Steroids - with 17alpha-methyl structure - depot preparations 100 mg - other preparations 150 mg - with other structures 3 000 mg b) endogenous Anabolic Androgenic Steroids not small amount of Androstenediol 3 000 mg androstenedione 3 000 mg Stanolone, synonymous with dihydrotestosterone 1 500 mg of dehydroepiandrosterone, dehydroepiandrosterone (DHEA) - depot preparations synonym 144 mg - other preparations 3 000 mg of testosterone - depot preparations 632 mg - transdermal preparations 1 500 mg - other preparations 3 000 mg 2.
Other anabolic agents not small amount of clenbuterol of 2.1 mg selective androgen receptor modulators (SARMs) 90 mg of Tibolone 75 mg Zeranol 4.5 mg Zilpaterol 4.5 mg II) peptide hormones, growth factors and related substances of 1. erythropoiesis stimulating substances not small amount of erythropoietin human (EPO) 24 000 IE Epoetin alfa, alfa beta, delta, omega, theta, zeta and analog recombinant human Erythropoetine d be Poetin (dEPO) 120 µg methoxy polyethylene glycol-Epoetin beta , synonymous with PEG-Epoetin beta, continuous erythropoiesis receptor Activator (CERA) 90 µg Peginesatid, synonymous with Hematid 5 mg of 2. chorionic gonadotrophin (CG) and luteinizing hormone (LH) no small amount of chorionic gonadotropin (HCG) 7 500 IE Choriogonadotropin alfa 250 µg Lutropin alfa 2 250 IE of 3 Corticotropine no small amount of corticotropin 1 200 IE Tetracosacaride - depot preparations 12 mg - other preparations of 0.25 mg 4. growth hormone, re leasing factors, re leasing peptides and growth factors not small amount of somatropin , synonymous with growth hormone human, growth hormone (GH) 16 mg Somatrem, synonymous with somatotropin (methionyl), human 16 mg growth hormone re leasing factors, synonymous with growth hormone releasing hormones (GHRH) 1.5 mg Sermorelin Somatorelin and peptides with equal effect, synonymous with growth hormone releasing peptides (GHRP) mecasermin, synonymous with insulin-like growth factor 1, insulin-like growth factor-1 (IGF-1) IGF-1 analogues of 60 mg 3 mg III) hormones and metabolic modulators 1 aromatase no small amount of aminoglutethimide 30 000 mg of anastrozole 30 mg Androsta-1 , 4, 6-triene-3,17-Dione, synonym Androstatriendion 3 000 mg-4-Androsten-3,6,17-trion (6-oxo) 6 000 mg of exemestane 750 mg Formestane 600 mg letrozole 75 mg Testolactone of 6 000 mg 2. selective estrogen receptor modulators (SERMs) no small amount of raloxifene 1 680 mg tamoxifen 600 mg Toremifen 1 800 mg 3.
Other antiestrogen substances not small amount of clomiphene 509 mg Cyclofenil 4 200 mg of fulvestrant 250 mg 4. changing Myostatinfunktionen substances Myostatinhemmer not small amount Stamulumab 450 mg 5. metabolic modulators not small amount of insulin 400 IE PPARδ (peroxisome proliferator activated receptor Delta)-agonists, synonymous with PPAR delta agonist 75 mg GW 501516, synonymous with GW 1516 AMPK (PPARδ-AMP-activated protein kinase) - axis agonists 7 000 mg AICAR